Atyr Pharma Inc

ATYRNASDAQ · USD
0.34USD-0.04 (-10.03%)
332

Atyr Pharma Inc (ATYR) Options Open Interest

ATYR options open interest is 33,808 contracts. The 2-week average daily volume is 147 contracts across the chain.

Read more

Monitoring ATYR open interest helps you see where real money is positioned on Atyr Pharma Inc's options and which strikes are attracting the most commitment from traders. Atyr Pharma Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ATYR options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ATYR options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Atyr Pharma Inc to settle.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders.

It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ATYR open interest is concentrated. Our scanner maps Atyr Pharma Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Atyr Pharma Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
0.50—0.050.05229%+0.424411
1.00—0.050.05399%+0.31836
1.50—0.100.10619%+0.45410
2.00—0.250.251,000%+0.71970
3.00—0.650.651,000%+0.66260
Puts
0.50—0.250.25447%-0.377113
1.000.251.000.63236%-0.91030
1.500.751.501.13312%-0.91500
2.001.351.801.5854%-1.00000
3.002.253.002.63442%-0.90680

As of September 23, 2026

Follow the money

Track ATYR open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial